Skip to content
healthcare.dev

Mirvaso

NDC 0299-5980, brimonidine tartrate, gel, from Galderma Laboratories, L.P..

Product NDC
0299-5980
Status
Listed
Labeler
Galderma Laboratories, L.P.
Dosage form
GEL
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA204708
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0299-5980 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BRIMONIDINE TARTRATE5 mg/g

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
0299-5980-00002995980001 TUBE in 1 BLISTER PACK (0299-5980-00) / 2 g in 1 TUBE
0299-5980-02002995980022 g in 1 TUBE (0299-5980-02)
0299-5980-300029959803030 g in 1 TUBE (0299-5980-30)
0299-5980-35002995980351 BOTTLE, PUMP in 1 CARTON (0299-5980-35) / 30 g in 1 BOTTLE, PUMP
0299-5980-450029959804545 g in 1 TUBE (0299-5980-45)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f6a4353f-ae69-4214-901f-e5d42a6fbde7
  • NADAC price for package 00299598035

    GET /v1/drugs/nadac/00299598035

Use it

Look up 0299-5980 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0299-5980 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0299-5980. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.